Analyst Price Targets — ALL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 9, 2026 12:01 pm | — | Mizuho Securities | $281.00 | $207.55 | TheFly | Allstate price target raised to $281 from $255 at Mizuho |
| February 7, 2026 1:16 am | — | Goldman Sachs | $238.00 | $207.55 | TheFly | Allstate price target raised to $238 from $227 at Goldman Sachs |
| February 6, 2026 2:19 pm | Elyse Greenspan | Wells Fargo | $228.00 | $212.13 | TheFly | Allstate price target raised to $228 from $223 at Wells Fargo |
| January 14, 2026 12:31 pm | — | Mizuho Securities | $255.00 | $197.65 | TheFly | Allstate price target raised to $255 from $254 at Mizuho |
| January 13, 2026 11:49 am | — | Wells Fargo | $223.00 | $208.66 | TheFly | Allstate price target raised to $223 from $216 at Wells Fargo |
| January 7, 2026 9:41 pm | — | Goldman Sachs | $227.00 | $207.27 | TheFly | Allstate price target lowered to $227 from $243 at Goldman Sachs |
| January 7, 2026 1:03 pm | — | Evercore ISI | $225.00 | $208.97 | TheFly | Allstate price target lowered to $225 from $233 at Evercore ISI |
| December 16, 2025 11:11 am | Bob Huang | Morgan Stanley | $215.00 | $211.69 | TheFly | Allstate downgraded to Equal Weight from Overweight at Morgan Stanley |
| December 15, 2025 9:19 pm | Yaron Kinar | Mizuho Securities | $254.00 | $211.69 | TheFly | Allstate initiated with an Outperform at Mizuho |
| November 26, 2025 12:38 pm | Harry Fong | Roth Capital | $240.00 | $212.65 | TheFly | Allstate price target raised to $240 from $230 at Roth Capital |
Latest News for ALL
The Allstate Corporation (ALL) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
Stock News Oil jumps on Middle East conflict: Exxon Mobil (XOM) and Chevron (CVX) gained premarket as Brent briefly topped $82 and WTI rose ~7.5% after U.S.-Isr
Becker Capital Management Inc. trimmed its stake in shares of The Allstate Corporation (NYSE: ALL) by 1.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 190,919 shares of the insurance provider's stock after selling 2,447 shares during the quarter. Allstate accounts
Allstate delivers robust profitability, with Q4 EPS of $14.31 and full-year EPS of $34.83, outpacing expectations. Auto and homeowners' underwriting results are excellent, with combined ratios well below 95% and premium growth supporting margins. Capital returns remain strong, highlighted by an 8% dividend increase, a new $4 billion buyback, and a secure balance sheet.
DVA, ALL, and PAX it to the Zacks Rank #1 (Strong Buy) growth stocks list on February 27, 2026.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.